JEP 401, integrated into JDK 28, introduces value objects. These new class instances feature final fields, altered behavior ...

Embabel has reached its 1.0 release, providing a framework for AI agents on Java It allows Java and Kotlin developers to ...

Go 1.27 adds generic methods, post-quantum cryptography, a rewritten JSON library and a UUID package, drawing strong ...

U.S. President Donald Trump's plan to impose tariffs on generic drugs will lead to patients in the U.S. paying higher prices, warned the CEO of Indian pharmaceutical company Dr Reddy's. Manufacturing ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for ...

Trump has spent much of his presidency using the threat of levies to extract concessions from the pharmaceutical industry. Makers of brand-name medicines have rushed to announce U.S. investment deals ...

US President Donald Trump plans to introduce 100% import tariffs on generic pharmaceuticals in 2028, rising to a 200% rate the following year. Credit: Rawpixel.com / Shutterstock.com. Following a ...

Donald Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, as part of a drive to reduce the country's reliance on imported medicines. One might be ...

President Donald Trump announced Tuesday that imported generic drugs will remain tariff-free for the next two years before facing steep new import duties, saying the move is designed to encourage ...

President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.

A stepped tariff schedule targets generics only, preserving existing treatment for patented and innovative drugs while signaling punitive intent for firms that do not invest in U.S. plant and ...